This article may contain affiliate links that Microsoft and/or the publisher may receive a commission from if you buy a product or service through those links.

ResMed (NYSE:RMD), a leader in sleep apnea and respiratory care solutions, reported strong fiscal 2025 second-quarter earnings on Thursday, Jan. 30. The medical device company outperformed analyst ...